| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 03/06/2002 | EP1183330A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
| 03/06/2002 | EP1183272A2 49 human secreted proteins |
| 03/06/2002 | EP1183270A2 Novel organic anion transport proteins |
| 03/06/2002 | EP1183269A1 Attenuated microorganisms for the treatment of infection |
| 03/06/2002 | EP1183049A2 Modification of biological elements |
| 03/06/2002 | EP1183040A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| 03/06/2002 | EP0820516B1 Exopolysaccharide degrading enzyme and use of the same |
| 03/06/2002 | EP0726958B1 A new cephalosporin c acylase |
| 03/06/2002 | CN1339067A Synthetic and chimeric promoters, expresion cassettes, plasmids, vectors, transgenic plants and seeds containing them, and method for producing them |
| 03/06/2002 | CN1339066A Alzheimer's disease secretase |
| 03/06/2002 | CN1339065A Method for preparing highly pure albumin solution |
| 03/06/2002 | CN1338940A Bidifobacterium in the treatment of inflammatory disease |
| 03/06/2002 | CN1338511A Sulfuraspergillus for high output of complex enzyme, its mutagenic screen and culutre process, and its application in preparing complex enzyme for feed by solid fermentation |
| 03/06/2002 | CN1338510A Artificial culture method of north cordyceps sporophores and its living product |
| 03/06/2002 | CN1338509A Process for preparing seeds of edible and medical ectomycorrhize fungus and its antificial cuture method |
| 03/06/2002 | CN1080311C Peptide related to human programmed cell death and DNA cencoding it |
| 03/06/2002 | CN1080309C Method for extracting useful component from substratum containing mycelium |
| 03/06/2002 | CN1080308C Antikanamycin gene originated from microbe |
| 03/06/2002 | CN1080307C Method and system for enhanced production of commercially important exoproteins in grampositive bacteria |
| 03/06/2002 | CN1080306C Adjusting and controlling factor for expression of nitrile solution deenzyme and gene thereof |
| 03/06/2002 | CN1080305C Preparation of hepatocellular cearcinoma oncogene |
| 03/06/2002 | CN1080304C Method for preparing modified L-protein for hepatitis B virus |
| 03/06/2002 | CN1080303C Antimicrobial proteins |
| 03/05/2002 | US6353153 Enhanced transport with a plastid membrane transport protein |
| 03/05/2002 | US6353093 gidB |
| 03/05/2002 | US6353092 Patched-2 polypeptide |
| 03/05/2002 | US6352972 Enhancing bone growth in mammals with bone morphogenic fusion protein |
| 03/05/2002 | US6352971 Polypeptides with amino acid sequences |
| 03/05/2002 | US6352850 Chitinase and method for preparing the same |
| 03/05/2002 | US6352848 Nucleotide sequences of amino acid sequences |
| 03/05/2002 | US6352841 Host cells and methods of producing proteins |
| 03/05/2002 | US6352839 Preparing virginiamycins from an engineered microorganisms, having the ability to prevent biosynthesis of the precursor antibiotic; the microorganism is cultured in the presence of a second precursor and the streptogramin analog is recovered |
| 03/05/2002 | US6352836 Dirofilaria and brugia thioredoxin peroxidase type-2 proteins and uses thereof |
| 03/05/2002 | CA2356553A1 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 03/05/2002 | CA2079463C Live vaccines |
| 02/28/2002 | WO2002016944A2 Synthetic nucleic acid molecule compositions and methods of preparation |
| 02/28/2002 | WO2002016937A1 Method of screening remedy for heart failure |
| 02/28/2002 | WO2002016638A1 METHOD FOR IDENTIFYING SUBSTANCES USEFUL FOR TREATING INFLAMMATION USING THE RESPONSE ELEMENT TO THE IλBα ROR RECEPTOR |
| 02/28/2002 | WO2002016618A1 Aminopeptidase |
| 02/28/2002 | WO2002016612A2 Genes and proteins, and their uses |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016597A2 Lipid metabolism enzymes |
| 02/28/2002 | WO2002016595A2 Kidney-specific protein |
| 02/28/2002 | WO2002016594A2 Methods and reagents for molecular cloning |
| 02/28/2002 | WO2002016587A2 Microtubule-associated proteins and tubulins |
| 02/28/2002 | WO2002016585A2 Imidazoline receptor homologs |
| 02/28/2002 | WO2002016584A2 Process for the preparation of neutrophil inhibitory factor |
| 02/28/2002 | WO2002016567A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | WO2002016566A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/28/2002 | WO2002016561A2 Mfq-111, a novel human gtpase like protein |
| 02/28/2002 | WO2002016550A2 Antisense rna expression strategies effective against streptococcus thermophilus bacteriophage |
| 02/28/2002 | WO2002016433A2 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 02/28/2002 | WO2002016421A2 Altered ospa of borrelia burgdorferi |
| 02/28/2002 | WO2002016416A2 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | WO2002016415A2 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | WO2002016413A2 Cripto tumour polypeptide |
| 02/28/2002 | WO2002016390A1 21 human secreted proteins |
| 02/28/2002 | WO2002016389A1 23 human secreted proteins |
| 02/28/2002 | WO2002016388A1 21 human secreted proteins |
| 02/28/2002 | WO2002016387A1 12 human secreted proteins |
| 02/28/2002 | WO2002016385A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
| 02/28/2002 | WO2002016365A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/28/2002 | WO2002015939A2 Calycins |
| 02/28/2002 | WO2002015846A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001081380A3 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001078796A9 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 02/28/2002 | WO2001077334A3 Lactococcus lactis genome, polypeptides and uses |
| 02/28/2002 | WO2001075112A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/28/2002 | WO2001075064A3 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 02/28/2002 | WO2001073083A3 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use |
| 02/28/2002 | WO2001073029A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/28/2002 | WO2001070984A3 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 02/28/2002 | WO2001068852A3 Apolipoprotein-a-i regulation of t-cell signalling |
| 02/28/2002 | WO2001064888A3 Kunitz domain polypeptide zkun8 |
| 02/28/2002 | WO2001055327A3 Nucleic acids, proteins, and antibodies |
| 02/28/2002 | WO2001053339A3 Egg specific surface proteins |
| 02/28/2002 | WO2001051639A3 Everninomicin biosynthetic genes |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001038500A3 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same |
| 02/28/2002 | WO2001031029A3 Human sphingosine kinase gene |
| 02/28/2002 | WO2001027284A3 Recombinant megalomicin biosynthetic genes and uses thereof |
| 02/28/2002 | WO2001025469A3 Method for preparing steroids modified by yeast fermentation |
| 02/28/2002 | WO2001023414B1 Immunologically significant herpes simplex virus antigens |
| 02/28/2002 | WO2001021808A3 Lactic acid bacteria transformed to be provided with respiratory metabolism |
| 02/28/2002 | WO2001015755A3 Methods and compositions for delivery of pharmaceutical agents |
| 02/28/2002 | WO2000077037A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/28/2002 | WO2000050566A3 Genes encoding insect odorant receptors and uses thereof |
| 02/28/2002 | US20020026655 Genetically engineered Salmonella for use in the treatment of cancer |
| 02/28/2002 | US20020026046 Mixing composition with reducing agent, heating; wherein any ribonucleases in composition are substantially inactivated or inhibited |
| 02/28/2002 | US20020026040 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases |
| 02/28/2002 | US20020026037 For diagnosing and treating disorders related to this novel human protein such as disorders related to the vascular and lymphatic systems |
| 02/28/2002 | US20020025930 Ras-like protein |
| 02/28/2002 | US20020025918 Polypeptides |
| 02/28/2002 | US20020025571 Elimination of xylose and preferential sugars plant hydrolysates; obtain sample, incubate with fungi, filter mix, monitor sample for xylose |
| 02/28/2002 | US20020025566 From dipeptides |
| 02/28/2002 | US20020025550 Methods for producing highly phosphorylated lysosomal hydrolases |